Vaccine Electronic Safety Reporting Guidelines Follow Drug Model
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA draft guidance explains procedures sponsors should use for electronic submissions to the Vaccine Adverse Event Reporting System when new requirements take effect in June 2015.